BON Company Profile and Key Details

The latest quarter delivered EPS of $0.22. The next quarter is forecast at $nan. Next year's EPS is expected at $3.57. Bon Natural Life Limited earnings surprise history is a mixed track record. The quarter that ended January 28, 2025, missed forecasts by -99.73%. The prior quarter beat by -100.33%. Over the last six quarters, Apple has recorded several small beats. These include -100.33% in September 09, 2024.

Bon Natural Life Limited has 6.09 million shares outstanding. The public float is 6.00 million shares, elevated short interest at 0.27% of float. This equals 16.39 thousand shares. The short ratio is 2.38 days. Institutional investors hold 0.26% of the float. Insiders own 0.01%.

Short-term trend indicators are bullishly aligned (SMA20 0.25%, SMA50 -1.32%, SMA200 -1.58%). The stock’s 14-day RSI is 49.07 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -97.78% below its high and over 43.68% above its low. Average 10-day trading volume of 5.28 thousand shares is below the 3-month average of 9.03 thousand, indicating normal recent market interest.

Bon Natural Life Limited (NASDAQ:BON) closed at $1.11 USD, losing -$0.04 (-3.45%) from the previous close of $1.15. The stock is currently mid-range between its 52-week high and low $1.05 and $2.34. With a market capitalization of about $6.76 million, Bon Natural Life Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.24). Key stats such as the average daily volume over the past year has been around 8.95 thousand shares, volume is running light vs its 52-week average. Headquartered in Xi'an, SA, Bon Natural Life Limited operates in the Basic Materials sector and the Chemicals - Specialty industry. Led by CEO Yongwei Hu, the company employs approximately 96 people and listed since June 24, 2021. Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts.

Bon Natural Life Limited trades at a P/E ratio of -4.89, slightly below the S&P 500 average, with a price-to-sales ratio of 0.37 and a price-to-book ratio of 0.05 suggesting the stock is closer to book value. The P/FCF stands at -1.62, also below market averages.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Bon Natural Life Limited (NASDAQ:BON) shares are flat 4.4% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Bon Natural Life Limited trading at a premium to the broader market with a P/E of -4.89. Our AI forecast model points to short-term strength (4.48% over two weeks), a medium-term fall (-57.67% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Bon Natural Life Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 4.48%, with price expected at $1.16 by September 24, 2026, within a range of $1.13 to $1.19 3-Month Outlook: Projected fall of -57.67%, reaching $0.47 by December 09, 2026, with a range of $0.11 to $0.81. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 10, 2027, within a range of $0.00 to $1.88.